| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus epidermidis (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox)  |
7 |
| Staphylococcus epidermidis (methicillin-susceptible) |
2 |
4 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
374 |
| Staphylococcus epidermidis (methicillin-susceptible) |
2 |
4 |
1 － 16 |
Cefixime (Suprax) |
1492 |
| Staphylococcus epidermidis (methicillin-susceptible) |
>2 |
>32 |
0.5 － >32 |
Ceftriaxone (Rocephin) |
102 |
| Staphylococcus epidermidis (methicillin-susceptible) |
4 |
16 |
0.25 － 128 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
113 |
| Staphylococcus epidermidis (methicillin-susceptible) |
4 |
16 |
0.25 － 128 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
113 |
| Staphylococcus epidermidis (methicillin-susceptible) |
8 |
8 |
4 － 16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
952 |
| Staphylococcus epidermidis (methicillin-susceptible) |
16 |
32 |
16 － >64 |
Ceftibuten (Cedax) |
1492 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.12 |
? － ? |
Grepafloxacin (Raxar) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.13 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.13 |
? － ? |
Trovafloxacin (Trovan) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.25 |
? － ? |
Clinafloxacin (PD 127391) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.25 |
? － ? |
Gatifloxacin (Tequin) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.25 |
? － ? |
Sparfloxacin (AT-4140, Zagam) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.375 |
≤0.03 － 0.25 |
Dalbavancin |
1112 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.375 |
? － ? |
Dalbavancin |
1112 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
0.5 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
1 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
1.5 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1112 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
2 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
240 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
240 |
| Staphylococcus epidermidis (methicillin-susceptible) |
>- |
>4 |
? － ? |
Ofloxacin (Floxin) |
341 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
8 |
? － ? |
Teicoplanin (Targocid) |
1112 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
- |
0.031 － ? |
Retapamulin |
609 |
| Staphylococcus epidermidis (methicillin-susceptible) |
- |
- |
0.5 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
609 |
| Staphylococcus epidermidis (meticillin-resistant) |
- |
- |
0.06 － 1 |
Daptomycin (Cubicin) |
1261 |
| Staphylococcus epidermidis (meticillin-resistant) |
- |
- |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
1261 |
| Staphylococcus epidermidis (meticillin-susceptible) |
- |
- |
0.06 － 0.5 |
Daptomycin (Cubicin) |
1261 |